228 related articles for article (PubMed ID: 3565366)
21. Epidemiology of the toxic oil syndrome.
Philen RM; Posada de la Paz M; Hill RH; Schurz HH; Abaitua Borda I; Gómez de la Cámara A; Kilbourne EM
Arch Toxicol Suppl; 1997; 19():41-52. PubMed ID: 9079193
[No Abstract] [Full Text] [Related]
22. Analytical measurements of products of aniline and triglycerides in oil samples associated with the toxic oil syndrome.
Schurz HH; Hill RH; Philen RM; Posada de la Paz M; Abaitua Borda I; Kilbourne EM; Bernert T; Needham LL
Arch Toxicol Suppl; 1997; 19():53-64. PubMed ID: 9079194
[No Abstract] [Full Text] [Related]
23. Clinical, pathologic, and immunopathologic manifestations of the toxic oil syndrome. Analysis of fourteen cases.
Phelps RG; Fleischmajer R
J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):313-24. PubMed ID: 3279088
[TBL] [Abstract][Full Text] [Related]
24. The toxic oil syndrome in Spain. Was it due to a combined action of trichothecene mycotoxins and of inhibitors of carboxyesterase?
Schoental R
Hum Toxicol; 1988 Jul; 7(4):365-6. PubMed ID: 3410487
[No Abstract] [Full Text] [Related]
25. A multisystemic disease caused by adulterated rapeseed oil.
Pascual-Castroviejo I
Brain Dev; 1988; 10(2):84-7. PubMed ID: 3291629
[TBL] [Abstract][Full Text] [Related]
26. Toxic oil syndrome.
Beranek JT
Am Heart J; 1991 Dec; 122(6):1792-3. PubMed ID: 1957784
[No Abstract] [Full Text] [Related]
27. [Toxic oil syndrome. Etiology, hypotheses and mechanisms].
Craan AG; Rodriguez-Alarcia P
Union Med Can; 1987 Jan; 116(1):32-6, 39. PubMed ID: 3564176
[No Abstract] [Full Text] [Related]
28. The neurotoxicological aspects of the toxic oil syndrome (TOS) in Spain.
Altenkirch H; Stoltenburg-Didinger G; Koeppel C
Toxicology; 1988 Apr; 49(1):25-34. PubMed ID: 3287691
[TBL] [Abstract][Full Text] [Related]
29. Mortality among people affected by toxic oil syndrome.
Abaitua Borda I; Kilbourne EM; Posada de la Paz M; Diez Ruiz-Navarro M; Gabriel Sanchez R; Falk H
Int J Epidemiol; 1993 Dec; 22(6):1077-84. PubMed ID: 8144289
[TBL] [Abstract][Full Text] [Related]
30. 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?
Mayeno AN; Belongia EA; Lin F; Lundy SK; Gleich GJ
Mayo Clin Proc; 1992 Dec; 67(12):1134-9. PubMed ID: 1469924
[TBL] [Abstract][Full Text] [Related]
31. Toxic oil syndrome.
Fitzpatrick KC
Am Heart J; 1992 Jun; 123(6):1722-3. PubMed ID: 1595563
[No Abstract] [Full Text] [Related]
32. The eosinophilia-myalgia syndrome and the toxic oil syndrome. Pursuing parallels.
Hertzman PA
Adv Exp Med Biol; 1996; 398():339-42. PubMed ID: 8906286
[No Abstract] [Full Text] [Related]
33. Pathology of "toxic oils" and selected metals in the MRL/lpr mouse.
Koller LD; Stang BV; de la Paz MP; Ruiz Mendez MV
Toxicol Pathol; 2001; 29(6):630-8. PubMed ID: 11794379
[TBL] [Abstract][Full Text] [Related]
34. Cytokine mRNA expression in lung tissue from toxic oil syndrome patients: a TH2 immunological mechanism.
del Pozo V; de Andrés B; Gallardo S; Cárdaba B; de Arruda-Chaves E; Cortegano MI; Jurado A; Palomino P; Oliva H; Aguilera B; Posada M; Lahoz C
Toxicology; 1997 Mar; 118(1):61-70. PubMed ID: 9074654
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous mucinosis in the toxic oil syndrome.
Fonseca E; Contreras F
J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):139-40. PubMed ID: 3805384
[No Abstract] [Full Text] [Related]
36. [Toxic oil syndrome and Paracetamol].
Posada de la Paz M
Aten Primaria; 2002 Mar; 29(4):258-60. PubMed ID: 11893309
[No Abstract] [Full Text] [Related]
37. Immunological aspects of the toxic oil syndrome.
Lahoz C; del Pozo V; Gallardo S; Cárdaba B; Jurado A; Cortegano I; del Amo A; Arrieta I; Palomino P
Arch Toxicol Suppl; 1997; 19():65-73. PubMed ID: 9079195
[No Abstract] [Full Text] [Related]
38. Pulmonary hypertension in patients with eosinophilia-myalgia syndrome or toxic oil syndrome.
Cheng TO
Mayo Clin Proc; 1993 Aug; 68(8):823-4. PubMed ID: 8331987
[No Abstract] [Full Text] [Related]
39. [Toxic oil syndrome and epidemiology].
Segura Benedicto A
Gac Sanit; 1996; 10(56):205-10. PubMed ID: 20524269
[No Abstract] [Full Text] [Related]
40. Clinical and pathologic manifestations of pulmonary vascular disease in the toxic oil syndrome.
Gomez-Sanchez MA; Saenz de la Calzada C; Gomez-Pajuelo C; Martinez-Tello FJ; Mestre de Juan MJ; James TN
J Am Coll Cardiol; 1991 Nov; 18(6):1539-45. PubMed ID: 1939959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
